Kayne Anderson Rudnick Investment Management’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.95K | Buy |
+136
| New | +$1.95K | ﹤0.01% | 849 |
|
2024
Q1 | – | Sell |
-4
| Closed | -$60 | – | 967 |
|
2023
Q4 | $60 | Hold |
4
| – | – | ﹤0.01% | 949 |
|
2023
Q3 | $45 | Hold |
4
| – | – | ﹤0.01% | 874 |
|
2023
Q2 | $40 | Sell |
4
-150
| -97% | -$1.5K | ﹤0.01% | 872 |
|
2023
Q1 | $1.45K | Sell |
154
-88
| -36% | -$827 | ﹤0.01% | 639 |
|
2022
Q4 | $2.96K | Sell |
242
-3,667
| -94% | -$44.8K | ﹤0.01% | 631 |
|
2022
Q3 | $49K | Sell |
3,909
-10,259,251
| -100% | -$129M | ﹤0.01% | 480 |
|
2022
Q2 | $201M | Sell |
10,263,160
-1,984,958
| -16% | -$39M | 0.64% | 60 |
|
2022
Q1 | $320M | Buy |
12,248,118
+905,307
| +8% | +$23.6M | 0.85% | 42 |
|
2021
Q4 | $322M | Sell |
11,342,811
-121,040
| -1% | -$3.44M | 0.74% | 50 |
|
2021
Q3 | $366M | Buy |
11,463,851
+513,789
| +5% | +$16.4M | 0.89% | 41 |
|
2021
Q2 | $380M | Buy |
10,950,062
+1,636,811
| +18% | +$56.8M | 0.94% | 36 |
|
2021
Q1 | $274M | Buy |
9,313,251
+1,078,211
| +13% | +$31.8M | 0.74% | 52 |
|
2020
Q4 | $253M | Buy |
8,235,040
+2,535,699
| +44% | +$77.8M | 0.73% | 49 |
|
2020
Q3 | $159M | Buy |
5,699,341
+1,204,266
| +27% | +$33.6M | 0.58% | 62 |
|
2020
Q2 | $96.1M | Buy |
4,495,075
+910,087
| +25% | +$19.4M | 0.4% | 70 |
|
2020
Q1 | $80.3M | Buy |
3,584,988
+760,580
| +27% | +$17M | 0.46% | 66 |
|
2019
Q4 | $83.2M | Buy |
2,824,408
+141,875
| +5% | +$4.18M | 0.4% | 73 |
|
2019
Q3 | $71.3M | Buy |
2,682,533
+152,131
| +6% | +$4.05M | 0.37% | 73 |
|
2019
Q2 | $85.5M | Buy |
2,530,402
+265,051
| +12% | +$8.96M | 0.45% | 57 |
|
2019
Q1 | $72.6M | Buy |
2,265,351
+451,963
| +25% | +$14.5M | 0.41% | 67 |
|
2018
Q4 | $57.2M | Buy |
1,813,388
+137,270
| +8% | +$4.33M | 0.39% | 72 |
|
2018
Q3 | $58.5M | Buy |
+1,676,118
| New | +$58.5M | 0.34% | 79 |
|